Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 8/20 | 0.65 |
| ▸ | POLB | P06746 | 1/20 | 0.65 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | CASP3 | P42574 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.38 |
| ▸ | GAA | P10253 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 3/20 | 0.38 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2950117 | 1.00 | MAPT (0.65) | MAPTPOLBHIF1ASMN1; SMN2L3MBTL1 | |
| SCHEMBL2949390 | 0.80 | MAPT (0.65) | MAPTPOLBHIF1ASMN1; SMN2NPC1 | |
| SCHEMBL2949393 | 0.80 | MAPT (0.65) | MAPTPOLBHIF1ASMN1; SMN2NPC1 | |
| SCHEMBL4379825 | 0.71 | ALDH1A1 (0.47) | MAPTPOLBHIF1ASMN1; SMN2MAOB | |
| SCHEMBL4379829 | 0.71 | ALDH1A1 (0.47) | MAPTPOLBHIF1ASMN1; SMN2MAOB | |
| SCHEMBL22171083 | 0.68 | ALDH1A1 (0.65) | MAPTPOLBSMN1; SMN2L3MBTL1TDP1 | |
| SCHEMBL4193697 | 0.67 | CASP6 (0.66) | MAPTPOLBHIF1ATDP1CYP2C19 | |
| SCHEMBL24712243 | 0.66 | RAB9A (0.77) | MAPTSMN1; SMN2L3MBTL1TDP1NPC1 | |
| SCHEMBL1405398 | 0.66 | ALDH1A1 (0.71) | MAPTPOLBSMN1; SMN2L3MBTL1TDP1 | |
| SCHEMBL1405397 | 0.66 | ALDH1A1 (0.71) | MAPTPOLBSMN1; SMN2L3MBTL1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7750556-B2 | Triazole derivatives and use thereof in organic light-emitting diodes (OLEDs) | BASF AKTIENGESELLSCHAFT (DE) | 2010-07-06 | — | — | US | disclosed |
| EP-1740673-B1 | TRIAZOLE DERIVATIVES AND USE THEROF IN ORGANIC LIGHT-EMITTING DIODES(OLEDS) | BASF SE (DE) | 2009-12-02 | — | — | EP | disclosed |
| US-20070188078-A1 | Triazole derivatives and use thereof in organic light-emitting diodes (oleds) | BASF AKTIENGESELLSCHAFT (DE) | 2007-08-16 | — | — | US | disclosed |
| EP-1740673-A1 | TRIAZOLE DERIVATIVES AND USE THEROF IN ORGANIC LIGHT-EMITTING DIODES(OLEDS) | BASF AKTIENGESELLSCHAFT (DE) | 2007-01-10 | — | — | EP | disclosed |
| WO-2005093007-A1 | TRIAZOLE DERIVATIVES AND USE THEREOF IN ORGANIC LIGHT-EMITTING DIODES (OLEDS) | BASF AKTIENGESELLSCHAFT (DE) | 2005-10-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070188078-A1 | Triazole derivatives and use thereof in organic light-emitting diodes (oleds) | OCIAD1, OGFOD1, OXA1L | MAPT 1691/4885POLB 2689/4885HIF1A 4654/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.